This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Influenza Vaccine from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Influenza Vaccine market.

Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of Influenza Vaccine including:
CSL
GSK
Sanofi
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
Hualan Bio
Sinovac Biotech
Changsheng Biological
SIOBP
Novartis
Simcere Vaxtec
Roche
BioDiem
Emergent BioSolutions
Gamma Vaccines
Seqirus

Market split by Type, can be divided into:
Inactivated Vaccine
Live Attenuated Vaccine

Market split by Application, can be divided into:
Pediatric
Adults

Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel

Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Table of Contents

Chapter 1 Influenza Vaccine Market Overview
1.1 Influenza Vaccine Definition
1.2 Global Influenza Vaccine Market Size Status and Outlook (2015-2030)
1.3 Global Influenza Vaccine Market Size Comparison by Region (2015-2030)
1.4 Global Influenza Vaccine Market Size Comparison by Type (2015-2030)
1.5 Global Influenza Vaccine Market Size Comparison by Application (2015-2030)
1.6 Global Influenza Vaccine Market Size Comparison by Sales Channel (2015-2030)
1.7 Influenza Vaccine Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Influenza Vaccine Market Segment Analysis by Player
2.1 Global Influenza Vaccine Sales and Market Share by Player (2018-2020)
2.2 Global Influenza Vaccine Revenue and Market Share by Player (2018-2020)
2.3 Global Influenza Vaccine Average Price by Player (2018-2020)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Influenza Vaccine Market Segment Analysis by Type
3.1 Global Influenza Vaccine Market by Type
3.1.1 Inactivated Vaccine
3.1.2 Live Attenuated Vaccine
3.2 Global Influenza Vaccine Sales and Market Share by Type (2015-2020)
3.3 Global Influenza Vaccine Revenue and Market Share by Type (2015-2020)
3.4 Global Influenza Vaccine Average Price by Type (2015-2020)
3.5 Leading Players of Influenza Vaccine by Type in 2020
3.6 Conclusion of Segment by Type
Chapter 4 Influenza Vaccine Market Segment Analysis by Application
4.1 Global Influenza Vaccine Market by Application
4.1.1 Pediatric
4.1.2 Adults
4.2 Global Influenza Vaccine Revenue and Market Share by Application (2015-2020)
4.3 Leading Consumers of Influenza Vaccine by Application in 2020
4.4 Conclusion of Segment by Application
Chapter 5 Influenza Vaccine Market Segment Analysis by Sales Channel
5.1 Global Influenza Vaccine Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Influenza Vaccine Revenue and Market Share by Sales Channel (2015-2020)
5.3 Leading Distributors/Dealers of Influenza Vaccine by Sales Channel in 2020
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Influenza Vaccine Market Segment Analysis by Region
6.1 Global Influenza Vaccine Market Size and CAGR by Region (2015-2030)
6.2 Global Influenza Vaccine Sales and Market Share by Region (2015-2020)
6.3 Global Influenza Vaccine Revenue and Market Share by Region (2015-2020)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Influenza Vaccine Market Share by Type
6.4.3 North America Influenza Vaccine Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Influenza Vaccine Market Share by Type
6.5.3 Europe Influenza Vaccine Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Influenza Vaccine Market Share by Type
6.6.3 Asia-Pacific Influenza Vaccine Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Influenza Vaccine Market Share by Type
6.7.3 South America Influenza Vaccine Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Influenza Vaccine Market Share by Type
6.8.3 Middle East & Africa Influenza Vaccine Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Influenza Vaccine Players
7.1 CSL
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on CSL
7.2 GSK
7.3 Sanofi
7.4 Mylan
7.5 AstraZeneca
7.6 Pfizer
7.7 Johnson & Johnson
7.8 Hualan Bio
7.9 Sinovac Biotech
7.10 Changsheng Biological
7.11 SIOBP
7.12 Novartis
7.13 Simcere Vaxtec
7.14 Roche
7.15 BioDiem
7.16 Emergent BioSolutions
7.17 Gamma Vaccines
7.18 Seqirus
Chapter 8 Upstream and Downstream Analysis of Influenza Vaccine
8.1 Industrial Chain of Influenza Vaccine
8.2 Upstream of Influenza Vaccine
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Influenza Vaccine
8.3.1 Leading Distributors/Dealers of Influenza Vaccine
8.3.2 Leading Consumers of Influenza Vaccine
Chapter 9 Development Trend of Influenza Vaccine (2021-2030)
9.1 Global Influenza Vaccine Market Size (Sales and Revenue) Forecast (2021-2030)
9.2 Global Influenza Vaccine Market Size and CAGR Forecast by Region (2021-2030)
9.3 Global Influenza Vaccine Market Size and CAGR Forecast by Type (2021-2030)
9.4 Global Influenza Vaccine Market Size and CAGR Forecast by Application (2021-2030)
9.5 Global Influenza Vaccine Market Size and CAGR Forecast by Sales Channel (2021-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification